Article Text

Download PDFPDF
Three new insulin preparations


Novo Actrapid (Neutral insulin injection-DFE), Nuso (neutral soluble insulin-British Insulin Manufacturers) and Novo Rapitard (Biphasic insulin injection-DFE) have recently become available for clinical use after protracted experiments on the solubility of highly purified insulins at various pH levels.1 2

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.